Hoverink biotechnologies inc
WebHoverink Biotechnologies, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Hoverink Biotechnologies, Inc.. Web12 de nov. de 2024 · Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic. November 12, 2024 14:30 ET Source: …
Hoverink biotechnologies inc
Did you know?
Web30 de abr. de 2024 · Lastest business and financial news on stocks, indices, commodities, bonds and many more like analyst opinions on Markets Insider. Web10 de nov. de 2024 · Contact: Hoverink Biotechnologies, Inc. 1801 Century Park East., 24th Floor Los Angeles, California [email protected]
Web27 de mar. de 2024 · Hoverink Biotechnologies doesn't have any recent trademark applications, indicating Hoverink Biotechnologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans. Trademark ... Web2 de abr. de 2024 · LOS ANGELES, CA, April 02, 2024 -- Hoverink Biotechnologies, Inc announced today that on February 28, 2024, HP White concluded its level II ballistics test for the U.S. Patent pending: BODY GLOBE...
Web9 de nov. de 2024 · Contact Data Hoverink Biotechnologies, Inc. 1801 Century Park East., 24th Floor Los Angeles, California 90067 866-443-4666 [email protected] WebWHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Cyrus Sajna , (the “Vice President”) in recognition and appreciation of services previously performed by the Vice President on behalf of the Company is an effective …
WebHoverink Biotechnologies Inc (Hoverink) formerly Hoverink International Holdings Inc, is a preclinical biopharmaceutical company that discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders.The company’s lead …
Web12 de nov. de 2024 · Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic. 12 nov. 2024 14h30 HE Source: Hoverink … fita led rgb philipsWeb28 de abr. de 2024 · LOS ANGELES, CA, April 27, 2024 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it intends to offer, subject to market and other conditions, $2.5 million of Series A Convertible Notes, through a Regulation D 506(b) offering to qualified buyers. fita led smart homeWebHOVERINK BIOTECHNOLOGIES, INC. EIN# 46-3590875. BOARD OF DIRECTORS RESOLUTION TO GRANT RESTRICTED STOCK GRANT AWARDS TO EXECUTIVES, BOARD MEMBERS AND CONSULTANTS. Upon a duly made, seconded and unanimously adopted consent, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC … fit a linear model theanot _theta 1Web11 de abr. de 2024 · -- Adaptive Biotechnologies said Wednesday it has entered a translational collaboration with Takeda Pharmaceutical to use its clonoSEQ assay to assess minimal residual disease in patients with... April 12, 2024 can fam physician impact factorWebHoverink Biotechnologies, Inc. Street Address 1 Street Address 2; 1801 CENTURY PARK EAST: 24TH FLOOR: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; LOS ANGELES: CALIFORNIA: 90067: 866-443-4666: 3. Related Persons. Last Name First Name Middle Name; Sajna: Cyrus: Street Address 1 Street Address 2; 1801 PARK … fit a light switchWebHoverink Biotechnologies, Inc. 1801 Century Park East., 24th Floor Los Angeles, California 90067 [email protected] ... fitality club diksmuidecan famvir be taken if allergy to valtrex